You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Claims for Patent: 7,790,680


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,790,680
Title:Stable pharmaceutical composition containing factor VIII
Abstract: The invention relates to a stable solid pharmaceutical composition comprising factor VIII. Such a composition is devoid of amino acids and comprises: (a) factor VIII; (b) a surfactant; (c) calcium chloride; (d) sucrose; (e) sodium chloride; (f) trisodium citrate; and (g) a buffer devoid of amino acids; and has a pH from 6 to 8 prior to lyophilization and after reconstitution in water for injection. The invention also relates to the liquid pharmaceutical composition obtainable after dilution of said stable solid pharmaceutical composition with sterile water optionally containing sodium chloride.
Inventor(s): White; Mary (Wrexham, GB), Webb; Paul (Wrexham, GB)
Assignee: Ipsen Pharma S.A.S. (Paris, FR)
Application Number:10/507,956
Patent Claims:1. A solid pharmaceutical composition comprising a lyophilized solution devoid of amino acids, wherein said solution comprises: (a) mature recombinant porcine factor VIII, wherein said mature recombinant porcine factor VIII extends from amino acid residue 20 to amino acid residue 1467 of; (b) a surfactant; (c) calcium chloride; (d) sucrose; (e) sodium chloride; (f) trisodium citrate; and (g) a buffer devoid of amino acids; wherein said solution has a pH from 6 to 8 prior to lyophilization and wherein said solid pharmaceutical composition results in a solution having a pH from 6 to 8 after reconstitution in water for injection.

2. The solid pharmaceutical composition of claim 1 wherein the surfactant is polysorbate.

3. The solid pharmaceutical composition of claim 2 wherein the surfactant is a polysorbate 80.

4. The solid pharmaceutical composition of claim 1 wherein the buffer devoid of amino acids is TRIS(hydroxymethyl)methylamine.

5. The solid pharmaceutical composition of claim 1 wherein the solution devoid of amino acids has a pH from 6.5 to 7.5 prior to lyophilization and wherein said solid pharmaceutical composition results in a solution having a pH from 6.5 to 7.5 after reconstitution in water for injection.

6. The solid pharmaceutical composition of claim 1, wherein the solution devoid of amino acids comprises: (a) a concentration of factor VIII from 50 to 10,000 porcine units/ml for mature recombinant porcine factor VIII; (b) a concentration of surfactant from above critical micellar concentration to 1% v/v; (c) a concentration of calcium chloride from 0.5 to 10 mM; (d) a concentration of sucrose from 5 to 50 mM; (e) a concentration of sodium chloride from 0.15 to 0.5 M; (f) a concentration of trisodium citrate from 1 to 50 mM; and (g) a concentration of a buffer devoid of amino acids from 1 to 50 mM.

7. The liquid pharmaceutical composition obtainable after dilution of a solid pharmaceutical composition of claim 1 with sterile water optionally containing sodium chloride.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.